Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-04-17

Clinical Trial Update: Study to Investigate the Effect of an Oral Diamine Oxidase Substitution (DAOsin) in Histamine Intolerant Patients on the Low Endogenous Diamine Oxidase Serum Activity [NA]

View source ↗

Summary

A clinical trial evaluating an oral diamine oxidase substitute (DAOsin) in histamine-intolerant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DAOsin (diamine oxidase)

Snippet

Sponsor: Sciotec Diagnostic Technologies GmbH | Conditions: Food Intolerance, Histamine Intolerance | NA | Status: COMPLETED